Asensus News
4 articlesTransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery
growth-positive
TransEntrix buys Israeli surgical analytics co MST
TransEnterix, Inc. has announced the acquisition of Israel-based surgical analytics company MST Medical Surgery Technologies Ltd. The acquisition will be completed in two phases, with MST Medical receiving $5.8 million in cash and 3,150,000 shares of TransEnterix common stock in the first phase. In the second phase, TransEnterix will pay $6.6 million in cash or stock within a year of closing. TransEnterix will transfer MST Medicals R&D team to a newly formed subsidiary, TransEnterix Israel, Ltd. The acquisition will allow TransEnterix to benefit from MST Medicals advanced visualization, scene recognition, artificial intelligence, machine learning, and data analytics technologies.
Acquisition
growth-positive
Medtech Company TransEnterix Acquires Assets of Israeli Medtech Company MST
TransEnterix Inc. has acquired the technology and intellectual property of MST Medical Surgery Technologies Ltd. in a stock and cash deal worth over $30 million. MSTs research and development team will become a subsidiary called TransEnterix Israel Ltd. The acquisition will enhance TransEnterixs digital laparoscopy offering and provide access to the Israeli technology scene.
Acquisition
TransEnterix Acquires Assets, Intellectual Property and Retains R&D Team from MST Medical Surgery Technologies
